
16/07/2025
A Proud Moment for Malawi & MLW! 🇲🇼
The guest of honor during the meeting, Dr. Joshua Matthias applauded the consortium and partners for the impact of the research.
"Not all research speaks directly to Malawi’s needs — but this one did. The Typhoid Vaccine trial was a game-changer, tailored specifically for Malawi, with the Ministry of Health, MLW, and partners working hand in hand," he said.
Typhoid results in more than 7 million cases and more tha 93,000 deaths globally each year, mostly among children and young adults in Asia and sub-Saharan Africa. This is an important milestone because typhoid conjugate vaccines (TCVs) can save lives.
Dr. Matthias continued to say: "This kind of collaboration ensures that research doesn’t just sit in journals but translates into real policies and life-saving public health interventions. From the rotavirus and pneumococcal vaccines to the malaria and now typhoid vaccines — we’re seeing real impact."
Kamuzu University of Health Sciences PATHWHO MalawiWorld Health Organization (WHO)University of Maryland Charles Regional Medical CenterCoalition against TyphoidMinistry Of Health - Malawi